GSK, Pfizer resolve patent lawsuit over RSV vaccines Ruchika Sharma8 April 2025 5:10 PM ISTPfizer and GlaxoSmithKline have agreed to end a lawsuit over alleged patent infringement involving their competing respiratory syncytial virus (RSV)...
Pfizer Abrysvo gets European Commission nod for RSV Lower Respiratory Tract Disease in adults aged 18-59 years Ruchika Sharma2 April 2025 4:45 PM ISTNew York: Pfizer Inc. has announced that the European Commission (EC) has issued a decision amending the marketing authorization for...
Pfizer RSV Vaccine Abrysvo gets USFDA ok for high-risk adults aged 18-59 MD Bureau23 Oct 2024 2:37 PM ISTThe approval for the vaccine, Abrysvo, in adults aged 18 to 59 was based on the results from a late stage trial in which two doses of the vaccine were...
Merck's RSV antibody Clesrovimab for infants shows 60.4% effectiveness in mid-to-late stage clinical trial MD Bureau19 Oct 2024 12:15 PM ISTThe drug clesrovimab also helped reduce RSV associated hospitalizations by 84.2% compared to placebo, Merck said.
RSV vaccine Abrysvo is protective through a second year: Pfizer Ruchika Sharma3 March 2024 12:00 PM ISTNew York: Pfizer has said a single dose of its new respiratory syncytial virus (RSV) vaccine Abrysvo maintained its ability to protect against the...
Pfizer gets European Commission marketing nod for RSV vaccine Abrysvo to protect infants, older adults Ruchika Sharma27 Aug 2023 11:00 AM ISTNew York: Pfizer Inc. has announced that the European Commission (EC) has granted marketing authorization for ABRYSVO, the company’s bivalent...
First Vaccine for Pregnant Individuals to Prevent RSV in Infants approved by FDA Dr. Kamal Kant Kohli22 Aug 2023 12:00 PM ISTRespiratory Syncytial Virus is a highly contagious virus that causes respiratory infections in individuals of all age groups. Furthermore it is the...
Pfizer maternal vaccine Abrysvo bags USFDA approval for RSV prevention in infants Ruchika Sharma22 Aug 2023 11:26 AM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO (Respiratory Syncytial Virus Vaccine),...
Pfizer sued by GSK for patent infringement over RSV vaccine Ruchika Sharma3 Aug 2023 12:30 PM ISTA GSK spokesperson said in a statement that intellectual property protections are the "foundation of research-based companies' ability to drive...
Pfizer bags USFDA nod for RSV vaccine Abrysvo for older adults Ruchika Sharma1 Jun 2023 12:00 PM ISTThe FDA's decision is based on the data from the pivotal Phase 3 clinical trial (NCT05035212) RENOIR (RSV vaccine Efficacy study iNOlder adults...
